Razoxane (ICRF 159) in psoriasis.
D004341:Drug Evaluation; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D011929:Razoxane / Q000627:therapeutic use*
D010879:Piperazines; D011929:Razoxane